Medication attitudes and beliefs in patients with psychotic and affective disorders on maintenance treatment

Human Psychopharmacology

Volumn 27, Issue 1, 2012, Pages 57-62

  Ng, Chee Hong ^a,c   Smith, Deidre J ^a   King, Joel ^b   Ong, Susan ^c   Schweitzer, Isaac ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c St Vincent's Mental Health   (Australia)

Author keywords

adherence; psychopharmacotherapy; treatment beliefs

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HEALTH BELIEF; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; SELF REPORT;

ADULT; ATTITUDE TO HEALTH; DATA COLLECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; OUTPATIENTS; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS;

EID: 84862786875     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1264     Document Type: Article

References (36)

1. Aikens JE, Nease DE, Klinkman MS,. 2008. Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med 6: 23-29.
2. Barnes TRE,. 1989. A rating scale for drug-induced akathisia. Br J Psych 154: 672-676. (Pubitemid 19154942)
3. Brown C, Battista D, Bruehlman R, Sereika SS, Thase ME, Dunbar-Jacob J,. 2005. Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care 43: 1203-1207. (Pubitemid 43012177)
4. Bulloch AG, Patten SB,. 2010. Non-adherence with psychotropic medications in the general population. Soc Psychiat Epidemiol 45: 47-56.
5. Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC,. 2006. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care 44: 300-303. (Pubitemid 43755432)
6. Clatworthy J, Bowskill R, Parham R, Rank T, Scott J, Horne R,. 2009. Understanding medication non-adherence in bipolar disorders using a necessity-concerns framework. J Affect Disord 116: 51-55.
7. Cunningham-Owens DG,. 1999. A guide to the extrapyramidal side effects of antipsychotic drugs. Cambridge University Press: Cambridge, MA.
8. Day JC, Wood G, Dewey M, Bentall RP,. 1995. A self-rating scale for measuring neuroleptic side-effects: validation in a group of schizophrenic patients. Br J Psych 166: 650-653.
9. Dolder CR, Lacro JP, Warren KA, Golshan S, Perkins DO, Jeste DV,. 2004. Brief evaluation of medication influence and beliefs. J Clin Psychopharmacol 24: 404-409.
10. Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S,. 2009. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm 66: 657-664.
11. Gilmer TP, Dolder CR, Lacro JP, et al,. 2004. Adherence to treatment with antipsychotic medication and health care costs among Medicard beneficiaries with schizophrenia. Am J Psychiatry 161: 692-699. (Pubitemid 38445514)
12. Gonzalez JS, Penedo FJ, Llabre MM, et al,. 2007. Physical symptoms, beliefs about medication, negative mood, and long term HIV medication adherence. J Behav Med 34: 46-55. (Pubitemid 47481224)
13. Guy W,. 1976. ECDEU Assessment Manual for Psychopharmacology-Revised. U.S. Department of Health Education and Welfare: Washington DC; 218-222.
14. Hamilton M,. 1960. Development of a rating scale for primary depressive illness. Br J Sociol Clin Psych 6: 278-296.
15. Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW,. 2004. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication and side effects. J Clin Psychiatry 65: 932-939.
16. Hogan TP, Awad AG, Eastwood R,. 1983. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13: 177-183. (Pubitemid 13132147)
17. Horne RE,. 2003. Treatment perception and self-regulation. In The Self-Regulation of Health and Illness Behaviour, Cameron LD, Leventhal H, (eds). Routledge: London; 138-153.
18. Kay S, Fizbein A, Opler L,. 1987. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276. (Pubitemid 18039085)
19. Lacro, JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV,. 2002. Prevalence of and risk factors for medication non-adherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63: 892-909. (Pubitemid 35231730)
20. Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M,. 2007. Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther 21: 311-316. (Pubitemid 47387472)
21. Mann DM, Ponieman D, Leventhal H, Halm EA,. 2009. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med 32: 278-284.
22. Masand PS, Narasimhan M,. 2006. Improving adherence in antipsychotic pharmacotherapy. Curr Clin Pharmacol 1: 47-56.
23. Menckeberg TT, Bouvy ML, Bracke M, et al,. 2008. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 64: 47-54. (Pubitemid 350297308)
24. Mitchell AJ, Selmes T,. 2007. Why don't patients take their medicine? Reasons and solutions in psychiatry. Adv Psychiatr Treat 13: 336-346. (Pubitemid 351148893)
25. Neame R, Hammond A,. 2005. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology 44: 762-767. (Pubitemid 41487205)
26. Ng C, Klimidis S,. 2008. Cultural factors and the use of psychotropic medications. In Ethno-Psychopharmacology: Advances in Current Practice, Ng CH, Lin KM, Singh B, Chiu E, (eds). Cambridge University Press: New York; 123-134.
27. Noordsy, DL, Phillips GA, Ball DE, Linde-Zwirble WT,. 2010. Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia. Patient Prefer Adherence 4: 263-271.
28. Perkins RE, Repper JM,. 1999. Compliance or informed choice. J Ment Health 8: 117-129. (Pubitemid 29227269)
29. Phatak HM, Thomas J,. 2006. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother 40: 1737-1742. (Pubitemid 44544869)
30. Rüsch N, Todd AR, Bodenhausen GV, Weiden PJ, Corrigan PW,. 2009. Implicit versus explicit attitudes toward psychiatric medication: Implications for insight and treatment adherence. Schizophr Res 112: 119-122.
31. Russell J, Kazantzis N,. 2008. Medication beliefs and adherence to antidepressants to primary care. N Z Med J 121: 14-20.
32. Simpson, GM, Angus, JW,. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212: 11-19.
33. Skevington SM, Lofty M, O'Connell KA,. 2004. The World Health Organization's quality of life assessment: Psychometric properties and results of the international field trial a report from the WHOQOL group. Qual Life Res 13: 299-310. (Pubitemid 38392258)
34. Sun SX, Liu GG, Christensen DB, Fu AZ,. 2007. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatments of schizophrenia in the United States. Curr Med Res Opin 23: 2306-2312.
35. The WHOQOL-BREF Group. 1998. Development of the World Health; Organisation WHOQOL-BREF quality of life assessment. Psychol Med 28: 551-558.
36. Voruganti LNP, Awad AG,. 2002. Personal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res 56: 37-46. (Pubitemid 34655466)